Diffusion-weighted imaging with histogram analysis of the apparent diffusion coefficient maps in the diagnosis of parotid tumours

Author(s):  
A.A.K. Abdel Razek ◽  
B.N. Gadelhak ◽  
I.A. El Zahabey ◽  
G.A.E.A. Elrazzak ◽  
B. Mowafey
2021 ◽  
Vol 11 ◽  
Author(s):  
Chengru Song ◽  
Peng Cheng ◽  
Jingliang Cheng ◽  
Yong Zhang ◽  
Shanshan Xie

BackgroundThis study aims to explore the utility of whole-lesion apparent diffusion coefficient (ADC) histogram analysis for differentiating nasopharyngeal lymphoma (NPL) from nasopharyngeal carcinoma (NPC) following readout-segmented echo-planar diffusion-weighted imaging (RESOLVE sequence).MethodsThirty-eight patients with NPL and 62 patients with NPC, who received routine head-and-neck MRI and RESOLVE (b-value: 0 and 1,000 s/mm2) examinations, were retrospectively evaluated as derivation cohort (February 2015 to August 2018); another 23 patients were analyzed as validation cohort (September 2018 to December 2019). The RESOLVE data were obtained from the MAGNETOM Skyra 3T MR system (Siemens Healthcare, Erlangen, Germany). Fifteen parameters derived from the whole-lesion histogram analysis (ADCmean, variance, skewness, kurtosis, ADC1, ADC10, ADC20, ADC30, ADC40, ADC50, ADC60, ADC70, ADC80, ADC90, and ADC99) were calculated for each patient. Then, statistical analyses were performed between the two groups to determine the statistical significance of each histogram parameter. A receiver operating characteristic curve (ROC) analysis was conducted to assess the diagnostic performance of each histogram parameter for distinguishing NPL from NPC and further tested in the validation cohort; calibration of the selected parameter was tested with Hosmer–Lemeshow test.ResultsNPL exhibited significantly lower ADCmean, variance, ADC1, ADC10, ADC20, ADC30, ADC40, ADC50, ADC60, ADC70, ADC80, ADC90 and ADC99, when compared to NPC (all, P < 0.05), while no significant differences were found on skewness and kurtosis. Furthermore, ADC99 revealed the highest diagnostic efficiency, followed by ADC10 and ADC20. Optimal diagnostic performance (AUC = 0.790, sensitivity = 91.9%, and specificity = 63.2%) could be achieved when setting ADC99 = 1,485.0 × 10−6 mm2/s as the threshold value. The predictive performance was maintained in the validation cohort (AUC = 0.817, sensitivity = 94.6%, and specificity = 56.2%)ConclusionWhole-lesion ADC histograms based on RESOLVE are effective in differentiating NPC from NPL.


2019 ◽  
Vol 2019 ◽  
pp. 1-9 ◽  
Author(s):  
Joao V. Horvat ◽  
Aditi Iyer ◽  
Elizabeth A. Morris ◽  
Aditya Apte ◽  
Blanca Bernard-Davila ◽  
...  

Objective. To investigate if histogram analysis and visually assessed heterogeneity of diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping can predict molecular subtypes of invasive breast cancers. Materials and Methods. In this retrospective study, 91 patients with invasive breast carcinoma who underwent preoperative magnetic resonance imaging (MRI) with DWI at our institution were included. Two radiologists delineated a 2-D region of interest (ROI) on ADC maps in consensus. Tumors were also independently classified into low and high heterogeneity based on visual assessment of DWI. First-order statistics extracted through histogram analysis within the ROI of the ADC maps (mean, 10th percentile, 50th percentile, 90th percentile, standard deviation, kurtosis, and skewness) and visually assessed heterogeneity were evaluated for associations with tumor receptor status (ER, PR, and HER2 status) as well as molecular subtype. Results. HER2-positive lesions demonstrated significantly higher mean (p=0.034), Perc50 (p=0.046), and Perc90 (p=0.040), with AUCs of 0.605, 0.592, and 0.652, respectively, than HER2-negative lesions. No significant differences were found in the histogram values for ER and PR statuses. Neither quantitative histogram analysis based on ADC maps nor qualitative visual heterogeneity assessment of DWI images was able to significantly differentiate between molecular subtypes, i.e., luminal A versus all other subtypes (luminal B, HER2-enriched, and triple negative) combined, luminal A and B combined versus HER2-enriched and triple negative combined, and triple negative versus all other types combined. Conclusion. Histogram analysis and visual heterogeneity assessment cannot be used to differentiate molecular subtypes of invasive breast cancer.


Sign in / Sign up

Export Citation Format

Share Document